Workflow
Pfizer to buy obesity startup Metsera for $4.9 billion; shares jump on Wall Street — Details here
MINT·2025-09-22 15:05

(Bloomberg) -- Pfizer Inc. will pay 4.9billionfortheobesitystartupMetseraInc.inabidtocatchuptorivaldrugmakersafterfailingtocompetewithitsownweight−lossmedications.TheUSdrugmakeragreedtobuyMetserafor4.9 billion for the obesity startup Metsera Inc. in a bid to catch up to rival drugmakers after failing to compete with its own weight-loss medications.The US drugmaker agreed to buy Metsera for 47.50 in cash per share, and further payments of up to 22.50pershareifthreespecificandregulatorymilestonesaremet,itsaidMonday,withatotalpotentialvalueof22.50 per share if three specific and regulatory milestones are met, it said Monday, with a total potential value of 7.3 billion. The deal represents a 43% premium to Metsera’s closing share price on Friday. Also Read | TC ...